Cargando…

Medical Utilization Associated with Palivizumab Compliance in a Commercial and Managed Medicaid Health Plan

BACKGROUND: Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections and hospitalization in infants. Palivizumab is currently the only available agent for prevention of RSV infection in highrisk infants. This high-cost injectable requires monthly dosing during the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diehl, Jocelyn L., Daw, Jessica R., Coley, Kim C., Rayburg, Renee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437717/ https://www.ncbi.nlm.nih.gov/pubmed/20044844 http://dx.doi.org/10.18553/jmcp.2010.16.1.23

Ejemplares similares

The Medicaid Cost of Palivizumab
por: Ambrose, Christopher S., et al.
Publicado: (2015)

Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
por: Pavilack, Melissa, et al.
Publicado: (2017)

A Systematic Review of Compliance with Palivizumab Administration for RSV Immunoprophylaxis
por: Frogel, Michael
Publicado: (2010)

Association of RSV-related hospitalization and non-compliance with Palivizumab among commercially insured infants: a retrospective claims analysis
por: Stewart, Dan L, et al.
Publicado: (2013)

Compliance with The RSV Immunoprophylaxis Dosing Schedule in The Polish Registry for Palivizumab (2008-2014)
por: Borecka, Róża, et al.
Publicado: (2019)

Comparison of Postpartum Health Care Use and Spending Among Individuals with Medicaid-Paid Births Enrolled in Continuous Medicaid vs Commercial Insurance
por: Gordon, Sarah H., et al.
Publicado: (2022)

Utilization Management Opportunities for Palivizumab for Prophylaxis of Respiratory Syncytial Virus Complications in Infants
por: Curtiss, Frederic R., et al.
Publicado: (2010)

Smoking Cessation Pharmacotherapy Utilization and Costs to a Medicaid Managed Care Plan
por: Corelli, Robin L., et al.
Publicado: (2021)

Palivizumab Compliance by Infants in Puerto Rico During the 2009–2010 Respiratory Syncytial Virus Season
por: Matías, Israel, et al.
Publicado: (2014)

Medicaid Behavioral Health Care Plan Satisfaction and Children's Service Utilization
por: Cook, Judith A., et al.
Publicado: (2004)

Development of a palivizumab specialty pharmacy management program
por: Harlan, Lana, et al.
Publicado: (2019)

Alcohol-Attributable Medical Costs in Commercially Insured and Medicaid Populations
por: Ozluk, Pelin, et al.
Publicado: (2022)

Medicaid Highlights: 2003 Medicaid Versus Commercial Beneficiary Experience with Care
por: Lied, Terry R.
Publicado: (2005)

Partial palivizumab prophylaxis and increased risk of hospitalization due to respiratory syncytial virus in a Medicaid population: a retrospective cohort analysis
por: Krilov, Leonard R, et al.
Publicado: (2014)

Evaluation of a Novel Web-Based Prior Approval Application for Palivizumab Prophylaxis of Respiratory Syncytial Virus in a State Medicaid Program
por: Lundeen, Kristin, et al.
Publicado: (2013)

The Effect of Florida Medicaid’s State-Mandated Formulary Provision on Prescription Drug Use and Health Plan Costs in a Medicaid Managed Care Plan
por: Munshi, Kiraat D., et al.
Publicado: (2018)

Medicaid Managed Care and the Health Care Utilization of Foster Children
por: Palmer, Makayla, et al.
Publicado: (2017)

Use of Utilization Management Methods in State Medicaid Programs
por: Buck, Jeffrey A., et al.
Publicado: (1996)

Characteristics and health care utilization of otherwise healthy commercially and Medicaid-insured preterm and full-term infants in the US
por: McLaurin, Kimmie K, et al.
Publicado: (2019)

Medicaid Highlights: Trends in Medicaid Prescribed Drug Expenditures and Utilization
por: Tepper, Carl D., et al.
Publicado: (2004)

HIV Testing among Outpatients with Medicaid and Commercial Insurance
por: Dietz, Patricia M., et al.
Publicado: (2015)

Variation in Medicaid and commercial coverage of cell and gene therapies
por: Beinfeld, Molly T., et al.
Publicado: (2023)

Public Reporting of Quality Information on Medicaid Health Plans
por: Felt-Lisk, Suzanne, et al.
Publicado: (2007)

Studies Recommending Palivizumab Restriction Have Serious Deficiencies
por: Stewart, Dan L.
Publicado: (2010)

Is immunization with palivizumab really effective in high-risk children?
por: Raguž, Marjana Jerković, et al.
Publicado: (2023)

The Impact of Medicaid Preferred Drug Lists on Utilization and Costs of Antipsychotic Medication
por: Frois, Christian, et al.
Publicado: (2013)

Should we use Palivizumab immunoprophylaxis for infants against respiratory syncytial virus? – a cost-utility analysis
por: Ginsberg, Gary M., et al.
Publicado: (2018)

The impact of Medicaid expansion on spending and utilization by older low‐income Medicare beneficiaries
por: Mellor, Jennifer M., et al.
Publicado: (2023)

Health status and utilization: Differences by Medicaid coverage and income
por: Kasper, Judith D.
Publicado: (1986)

Cost effectiveness of palivizumab in Spain: an analysis using observational data
por: Nuijten, Mark J., et al.
Publicado: (2009)

Neonatal outcomes following new reimbursement limitations on palivizumab in Italy
por: Belleudi, Valeria, et al.
Publicado: (2018)

Pulmonary Deposition of Radionucleotide-Labeled Palivizumab: Proof-of-Concept Study
por: Rajapaksa, Anushi E., et al.
Publicado: (2020)

Reappraisal of the Subtropical Guidelines on Palivizumab Prophylaxis in Congenital Heart Disease
por: Chiu, Shuenn-Nan, et al.
Publicado: (2022)

Respiratory syncytial virus and palivizumab prophylaxis in the COVID-19 era
por: Taylor, Richard S.
Publicado: (2021)

The Tennessee Medicaid medication therapy management program: early stage contextual factors and implementation outcomes
por: Hohmeier, Kenneth C., et al.
Publicado: (2021)

A post-incorporation study on the use of palivizumab in the Brazilian public health system
por: Batista, Joanna d’Arc Lyra, et al.
Publicado: (2021)

Medicaid's Complex Goals: Challenges for Managed Care and Behavioral Health
por: Gold, Marsha, et al.
Publicado: (2000)

Factors Associated With Postpartum Uninsurance Among Medicaid-Paid Births
por: Daw, Jamie R., et al.
Publicado: (2021)

Does Medicaid Managed Care Help Equalize Racial and Ethnic Disparities in Utilization?
por: Marton, James, et al.
Publicado: (2015)

Rotavirus vaccination in a Medicaid infant population from four US states: compliance, vaccination completion rate, and predictors of compliance
por: Calnan, Michaela, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8nc0gek7tscr1i12u35ni15d0j